Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-020628
Filing Date
2024-02-27
Accepted
2024-02-27 07:40:17
Documents
5
Effectiveness Date
2024-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 2024_s-8.htm S-8 99800
2 EX-5.1 beam-ex5_1.htm EX-5.1 15811
3 EX-23.1 beam-ex23_1.htm EX-23.1 3539
4 EX-FILING FEES beam-exfiling_fees.htm EX-FILING FEES 44555
5 GRAPHIC img172875881_0.jpg GRAPHIC 112846
  Complete submission text file 0000950170-24-020628.txt   320287
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277382 | Film No.: 24682013
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)